How Cannabis Eases Suffering for HIV/AIDS Patients

Photo Credit: MassRoots

Photo Credit: MassRoots

While HIV/AIDS treatments have proven effective for treating the virus itself and have significantly extended the lifespan of patients, they produce a wide range of negative side effects. Studies have shown cannabis may able to reduce these side effects associated with the medications, so that patients can continue to undergo treatment without discomfort. A study from 2014 in Canada found 38.5% of its study participants used cannabis while undergoing treatment for HIV/AIDS. Of those users, 80% reported cannabis relieved HIV-related stress and pain.

HIV/AIDS patients often lose their appetites, which results in rapid weight loss. The loss of nutrients exacerbates other symptoms and puts patients in danger of risking infections. In 2007, a study found cannabis increased caloric intake and body weight in spite of the negative side effects of HIV medications like nausea and vomiting. HIV/AIDS patients also experience pain, specifically peripheral neuropathy. In one study that looked at cannabis in relation to HIV-induced nerve pain found, 50% of patients smoked cannabis three times a daily for five days. These patients reported a 34% reduction in pain, results that are similar to the pain relief provided by traditional oral drugs. Lastly, there is evidence to suggest cannabis may act as an immune modulator and anti-viral agent, however this information has not been concluded in human trials. Another longitudinal study over the course of a decade found cannabis use was associated with lower viral loads.

This information has been provided by MassRoots and approved by our Chief Medical Officer. 

3 Benefits of THC

Photo Credit: MassRoots

Photo Credit: MassRoots

While THC is known for producing a psychoactive "high" for recreational users, medical marijuana patients and researchers recognize THC also has medicinal properties to it. THC is a cannabinoid that occurs naturally in the cannabis plant, and that is able to connect to receptors throughout the endocannabinoid system and in the brain and immune system. THC is already known for its ability to increase appetite, but this can be especially effective for treating nausea and vomiting and stimulating appetite in patients suffering from HIV or cancer. It has also effectively increased appetite in patient suffering from illnesses like anorexia or Alzheimer's. This helps users maintain a stable body mass.

Recently, CBD has been gaining a lot of attention for its efficacy in pain management, which could have a beneficial impact on the opioid epidemic. What isn't as well known, however, is that THC also has analgesic properties. Studies have found THC effectively treats pain associated with rheumatoid arthritis, cancer, headaches, menstrual pain, chronic bowel inflammation, and nerve damage. A study from the University of Michigan involving 185 patients found medical cannabis users experienced a 45% increase in their quality of life. Lastly, it is thought THC may help those who suffer from anxiety or depression. THC has fewer side effects than the commonly prescribed anti-depressant medications, and it can increase serotonin levels which helps relieve depression. 

This information has been brought to you by MassRoots and approved by our Chief Medical Officer. 

 

Studies Suggest Cannabis May Treat Herpes

Photo Credit: MassRoots

Photo Credit: MassRoots

Once infected with the herpes simplex virus (HSV), the virus lasts for life. Herpes is a prevalent virus, and according to the CDC, one in six Americans between 14 and 49 are infected with the virus. While outbreaks may be rare or infrequent, they consist of painful blisters and sores on the mouth and lips (HSV 1) or in the genital area (HSV 2) that can only be treated with ointments and creams when outbreaks occur.

Now, studies are showing topicals including cannabinoids might be the a valuable treatment option for patients with herpes. In 1980, a study published in the Journal of General Virology found THC stopped both herpes viruses from replicating and spreading. Later, in 1991, a study found THC suppressed viability of herpes by 80%, making it less infective and slowing its replication. Lastly, in 2004, in attempting to better understand how cannabis fights herpes, scientists found THC targets viral/cellular mechanisms, so that it works at the cellular level to combat herpes. Various cannabis oils and infused topicals can be applied to the skin to act transdermally and act at the cellular level. While THC specifically helps prevent the spread of herpes, topicals that also contain CBD can help reduce pain and inflammation.

This information has been brought to you by MassRoots and approved by our Chief Medical Officer. 

New Study Finds Regular Cannabis Use Associated with Lower Body Fat, No Loss in Bone Density

Photo Credit: Medical Marijuana Inc.

Photo Credit: Medical Marijuana Inc.

A new study from Oregon's Health and Science University have determined regular cannabis use results in lower body fat percentage. The study, which was published in Archives of Osteoporosis, determined of the 4,743 participants between ages 20-59 in the survey, those who used cannabis more than five times a month had a lower body mass index when compared to non-users. Carrie M. Nielson, who led the researchers, wrote, "Heavy users of cannabis had a lower mean BMI compared to that of never users, with a mean BMI being 26.7 kg/m2 in heavy users and 28.4 kg/m2 in never users." Additionally, cannabis use did not produce changes in bone mineral density of lumbar spine or proximal femur. In fact, while bone density decreases with age, cannabis has been found to interact with CB2 receptors to actually boost bone density. Heavy users of cannabis were also more likely to be physically active and for longer periods of time.

This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical Officer.  

Scientists Believe Cannabis Could Help Cure Alzheimer's Disease

Photo Credit: Medical Marijuana Inc.

Photo Credit: Medical Marijuana Inc.

According to researchers from the Salk Institute, certain cannabinoids like THC may have the potential to treat dementia and Alzheimer's disease by removing harmful protein plaques in the brain that are associated with dementia disorders like Alzheimer's. These plaques interfere with cell communication and the delivery of nutrients between neurons. Researchers from the Salk Institute administered THC to altered laboratory-grown human neurons that formed plaques and found the cannabinoid effectively broke down the buildup of these plaques and reduced cell inflammation. Because the Salk Institute is federally funded, it faces huge research barriers when it comes to studying cannabis. That said, researchers hope the next steps will be to conduct trials on mice and then, if all goes well, move on to human clinical trials. 

This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical Officer. 

Ways CBD Affects Your Brain

Photo Credit: Leaf Science

Photo Credit: Leaf Science

Cannabidiol (CBD) is a non-psychoactive cannabinoids found in cannabis, but this does not mean that it does not have effects on the brain. CBD travels to the endocannabinoid system and, while it doesn't bind with the CB1 receptor itself, it interacts with it in ways to prevent other cannabinoids like THC from binding with it, and thereby prevents them from producing psychoactive effects. CBD also increases levels of anandamide, a naturally occurring endocannabinoid responsible for regulating other bodily chemicals, in the brain. Researchers recently used imaging scans to better understand which areas of the brain respond to CBD's anti-anxiety properties, and found the cannabinoid reduced blood flow to regions linked with anxiety, like the hypothalamus, and reduced overall anxiety scores in participants. CBD also acts as an antidepressant by balancing endocannabinoid dysfunction and influencing serotonin receptors. CBD also interacts with CB2 receptors to reduce pain. One study found CBD ointment helped reduce joint inflammation and spontaneous pain in arthritis patients.

Contrary to popular belief, chemicals in marijuana interact with the CB2 receptors to provide neuroprotective properties, as opposed to neuron damaging properties. The U.S. Department of Health and Human Services even obtained a patent in 1999 claiming cannabis' chemical compounds help protect brain cells from neurodegenerative diseases like Parkinson's, Alzheimer's, and other forms of dementia. One study on animal models found CBD increased the number of viable brain cells and decreased the number of injured brain cells by more than 50% when it comes to brain injury. CBD is well known for its role in treating epilepsy. CBD produces anticonvulsant effects and protects brain cells by lowering the excitation of brain cells and minimizing excitotoxicity in epilepsy. CBD also supports the release of inhibitory neurotransmitters like GABA, thereby stopping the mechanism that directly contributes to seizures. Lastly, CBD has antipsychotic properties not unlike that of the antipsychotic drug amisulpride. In a study involving patients with schizophrenia, CBD produced similar effects to the pharmaceutical drug, and it was preferred by patients due its minimal side effects.

This information has been provided by Leaf Science and approved by out Chief Medical Officer.

Coping With Bipolar Disorder: How Medical Marijuana Can Help

Photo Credit: Medical Jane

Photo Credit: Medical Jane

Bipolar disorder (BPD) is a chronic mental illness characterized by extreme mood swings between uncontrollable highs and lows known as mania and depression. Symptoms of BPD may also mimic other illness symptoms, and many patients also suffer from other issues like anxiety disorder, thyroid disease, and migraines or headaches. There are four types of BPD that fall under bipolar disorder 1, bipolar disorder 2, cyclothymic disorder, or other specified and unspecified bipolar related disorders. While research is limited when it comes to medical marijuana for BPD, there are still some studies that suggest the medication could be beneficial. One review published by C.H. Ashton, et al., in the Journal of Psychopharmacology explored the potential for cannabinoids to treat BPD and found anecdotal reports suggested patients took medical cannabis to alleviate both mania and depression symptoms. Authors found THC and CBD, "may exert sedative, hypnotic, anxiolytic, antidepressant, antipsychotic and anticonvulsant effects..."

In 2012, Raphael J. Braga examined the cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. Braga compared clinical and neurocognitive measures in individuals with BPD to a history of cannabis use disorder (CUD) or no history of CUD, specifically looking at clinical and demographic variables and performance on neurocognitive tests. Researchers found those with CUD performed better on measures of attention, processing speed, and working memory. Another study published in PLOS ONE in 2015 asked 24 patients with BPD I or II to write in diaries for 6 days using Experience Sampling Methodology to look at the temporal associations between cannabis, affect, and BPD symptoms. The study found cannabis use coincided with a number of psychological effects, but that there was no evidence that those with BPD were using cannabis to self-medicate in minor fluctuations over the course of daily life.

Lastly, another study published in PLOS ONE in 2016 under Kelly Sagar, et al., looked at a larger study from 2008-2014 involving 12 BPD patients who used cannabis, 18 BPD patients who abstained, 23 cannabis users without BPD, and 21 controls without BPD who also abstained from use. All completed neuropsychological assessments, and some completed daily EMA assessments for four weeks. Researchers found no significant differences in cognitive function between BPD patients who used or did not use cannabis, meaning they did not suffer additional impairment, but BPD patients who regularly smoked cannabis reported reduced mood symptoms, which suggests marijuana may be able to stabilize mood.

This information has been provided by Medical Jane and approved by our Chief Medical Officer. 

 

Benefits of Medical Marijuana

Photo Credit: Medicinal Marijuana Association

Photo Credit: Medicinal Marijuana Association

As more states implement medical marijuana laws, and researchers become more interested in understanding the benefits of the medication, we are becoming learning more about the mysteries behind this plant and how it is able to target such a wide range of conditions and symptoms. Many conditions are accompanied by unbearable chronic pain, but now research has shown cannabis is not only an analgesic that provides effective pain relief, but that it does so without the risk of addiction or adverse side effects like its pharmaceutical counterparts. Physicians may prescribe medical marijuana for chronic muscle spasms, neuropathic pain, cancer-associated discomfort, and other pain issues.

Cancer and HIV patients often suffer from nausea and a decreased appetite, which prevents them from receiving the nutrition they need to aid recovery. Medical marijuana, however, has been shown to increase appetite and manage nausea. One of the specific cannabinoids in marijuana, CBD, reduces seizures in severe and treatment-resistant forms of epilepsy. Cannabis might also extend its benefits beyond physical health to mental health in the relief of psychiatric disorders and mental illness. Not only might it relieve anxiety and depression, but studies have found it could also help those who suffer from PTSD by alleviating feelings of fear or panic.

This information has been provided by the Medicinal Marijuana Association and approved by our Chief Medical Officer. 

New Study Shows Accessible Medical Marijuana Helps Fight Opioid Addiction

Photo Credit: U.S. Air Force photo by Airman Valerie Monroy

Photo Credit: U.S. Air Force photo by Airman Valerie Monroy

According to data published in Reuters and the Journal of Drug and Alcohol Dependence, states that have adopted medical marijuana programs witnessed hospitalization rates for opioid painkiller abuse drop by 23%, and opioid overdoses dropped by an average 13%. Author of the study, Yuyan Shi, looked at hospitals in 27 states from 1997-2014, of which 9 of the states passed medical marijuana laws within that time frame. Those states that passed these laws saw a significant reduction in opioid related hospitalization. This study supports other studies that found similar results, like that of John Hopkins University in 2016 which found states with medical marijuana programs witnessed a 25% decrease in opioid-related deaths. 

This information has been provided by Merry Jane and approved by our Chief Medical Officer. 

New Report: CBD Is Good for Anxiety

Photo Credit: High Times Magazine

Photo Credit: High Times Magazine

Neuroscientist and researcher Carl Stevenson from the University of Nottingham recently reviewed existing marijuana-related research and found evidence suggesting cannabidiol (CBD) may be able to reduce anxiety. Live Science reported data compiled from human trials suggests CBD reduces fear, resulting in a reduction of anxiety, by changing brain activity. One reviewed study from 1993 that was published in the Journal of Psychopharmacology found subjects who received CBD were less anxious when subjected to social phobia. Another study from 2011 found CBD helped people who became anxious in public speaking situations. These reviews are based on the few studies that have been performed on humans, as opposed to most trials which have been conducted on animal models like rodents. 

This information has been provided by High Times Magazine and approved by our Chief Medical Officer. 

Cannabis Reduces Seizures in 9/10 Adults With Epilepsy, Survey Finds

Photo Credit: Medical Marijuana Inc.

Photo Credit: Medical Marijuana Inc.

According to a nationwide Australian survey involving 976 respondents and published in Epilepsy & Behavior, cannabis effectively reduced seizures in both children and adults. The study, called the Epilepsy Action Australian study, found 14% of patients with epilepsy had used cannabis for treatment, and of those patients, 90% of adults and 71% of parents or guardians of children with epilepsy found cannabis reduced the frequency of seizures. The study found a correlation between past anti-seizure drugs and medical cannabis use in both adults and children, in that with every anti-seizure medication tried in the past, patients were 1.1 times more likely to experiment with cannabis as an alternative treatment. All respondents noted their main reasons for trying medical marijuana products was in an attempt to better manage their seizures that had proven resistant to traditional pharmaceutical options, and they hoped for a regimen with fewer and more favorable side effects.

The study's lead author, Anastasia Suraey, wrote, “Despite the limitations of a retrospective online survey, we can not ignore that a significant proportion of adults and children with epilepsy are using cannabis-based products in Australia, and many are self-reporting considerable benefits to their condition.” Co-author Carol Ireland added, “This highlights a growing need to educate consumers and health professionals on the use of cannabis by people with epilepsy, and to provide safe and timely access to cannabinoid medicine in order to lessen people’s reliance on illicit black market products.” This study partnered with the Lambert Initiative at the University of Sydney. 

This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical Officer. Find text of the study here

The Endocannabinoid System: A Beginner’s Guide

Photo Credit: Leaf Science

Photo Credit: Leaf Science

The physical and psychological effects of cannabis can all be attributed to its interaction with the body's endocannabinoid system (ECS). Cannabinoids are deemed the "chemical messengers" for the ECS, and they interact with cannabinoid receptors (categorized as CB1 or CB2 receptors) to provide a wide array of therapeutic relief. Some cannabinoids are endogenous, called endocannabinoids, and they are occur naturally within the body. Other exogenous cannabinoids, like those provided by cannabis, occur outside of the body but can similarly interact with the body's ECS. The list of functions the ECS is involved in seems endless, and it includes: appetite, metabolism, pain, sleep, mood, movement, temperature, memory and learning, immune function, inflammation, neural development, neuroprotection, cardiovascular function, digestion, and reproduction. In addition to regulating these functions, the ECS responds to illness to return the body to homeostasis. 

Because of its involvement in such a wide variety of bodily function, the endocannabinoid system could help treat a myriad of medical illnesses and conditions. Researchers and physicians are currently using medical marijuana and synthetic cannabinoids to target the system. Medical marijuana is commonly prescribed to treat chronic pain, nausea, multiple sclerosis, epilepsy, and palliative care. Synthetic cannabinoids are engineered to mimic the effects of natural cannabinoids in a more efficient way, and target specific parts of the system. Some synthetic cannabinoids include a synthetic THC call Marinol, used to reduce nausea and increase appetite for AIDS and cancer patients, and a synthetic cannabinoids similar to THC called Cesamet, which reduces vomiting in cancer patients and manages pain for fibromyalgia, multiple sclerosis, Parkinson's disease, and chronic pain.

This information has been provided by Leaf Science and approved by our Chief Medical Officer. 

Study: Cannabinoids Show Treatment Potential For Traumatic Brain Injury

Photo Credit: Medical Marijuana Inc.

Photo Credit: Medical Marijuana Inc.

A new study conducted by Lesley D. Schurman and Aron H. Lichtman, which can be found in Frontiers in Pharmacology, suggests cannabinoids may have the power to benefit traumatic brain injury (TBI). Researchers reviewed preclinical studies that looked at the potential for cannabinoids to reduce the neural damage associated with TBI, and found cannabinoids interacted with the endocannabinoid system to regulate its immune response in order to prevent brain damage caused by a TBI. Following an injury, the body releases mediators like proinflammatory cytokines that can be harmful and lead to oxidative stress, inflammation, and excitoxicity, but this study suggests cannabinoids can modulate this response. The researchers conclude, “The [endocannabinoid] system, through release of its endogenous ligands or by changes in cannabinoid receptor constitutive activity possesses promise in the treatment of diverse TBI pathway.”

This study supports the findings of other studies that similarly suggest cannabinoids, like both THC and CBD, have neuroprotective and anti-inflammatory properties that improve the survival rates of brain cells following a TBI. Other research has shown when cannabinoids are administered right after injury, they prevent the release of harmful mediators that cause brain damage.

This information has been provided by Medical Marijuana Inc, and you can find the text of Schurman and Lichtman's study here. This post has been approved by our Chief Medical Officer.

New Study Suggests CBD Could Help Treat Anxiety and Substance Abuse Disorder

Photo Credit: Medical Marijuana Inc.

Photo Credit: Medical Marijuana Inc.

A new study coming from the University of Nottingham suggests CBD could play a therapeutic role against anxiety-related substance abuse disorders. The team of researchers led by behavioral neurologist Dr. Carl Stevenson looked at studies surrounding the impact of CBD on fear and drug memory processes, and found CBD effectively reduced the expression of fear and drug memories. These findings suggest CBD not only could interfere with fear recollection and help those suffering phobias and PTSD, but also prevent relapse in those recovering from substance abuse disorders.

Researchers write, “Converging lines of evidence have established that acute CBD treatment is anxiolytic in both animals and humans...A growing number of preclinical studies also indicate that this drug reduces fear memory expression when given acutely. Importantly, CBD produces an enduring reduction in learned fear expression when given in conjunction with fear memory reconsolidation or extinction by disrupting the former and facilitating the latter. This makes CBD a potential candidate for testing as a pharmacological adjunct to psychological therapies or behavioural interventions used in treating PTSD and phobias.” He adds, “Understanding how cannabidiol regulates emotion and emotional memory processing may eventually lead to its use as a treatment for anxiety-related and substance abuse disorders. The published literature makes CBD a potential candidate for testing as a pharmacological support to psychological therapies or behavioural interventions used in treating post-traumatic stress disorder and phobias,”

You can find the text of this study on the Online Wiley Library website. This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical officer. 

MMJ for Lyme Disease

Photo Credit: Medical Marijuana Inc.

Photo Credit: Medical Marijuana Inc.

Lyme disease is a bacterial infection caused caused by deer ticks, and the disease produces a skin rash called erythema migrains, fever, chills, body aches, headache, fatigue, and sometimes nausea and vomiting. Lyme disease requires antibiotics, but if it's left untreated it can result in severe chronic joint pain, inflammation, and potentially neurological problems like meningitis, paralysis in the face, limb numbness, and impaired muscle movement.

Research suggests cannabis' antibacterial properties can help those affected by Lyme disease, and it's various properties can also help manage the symptoms associated with the disease. While research on the specific bacteria that causes Lyme disease is lacking, cannabinoids like THC and CBD are effective in reducing the activity of numerous other bacterias. Cannabis may also help relieve the symptoms of later stage Lyme disease. CBD and THC relieve pain, produce anti-inflammatory effects, and have anti-nausea properties. They can even relieve treatment-resistant pain, and their interaction with the endocannabinoid system regulates the immune system and suppresses inflammatory responses.

This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical Officer. 

The Beginner’s Guide to Consuming Medical Cannabis

Photo Credit: Medicinal Marijuana Association

Photo Credit: Medicinal Marijuana Association

Beginning a medical marijuana regimen can seem like a daunting task. Not only does the efficacy depend on a wide variety of factors, like the cannabinoid composition, vehicle, frequency, and dose of the medication, but the therapy also varies from patient to patient. For patients who don't know where to begin, here are some good tips across the board. Remember to start with a low dose and go slow when considering increasing it. The efficacy of the dosing regimen is highly dependent on the vehicle of administration one chooses. With some vehicles, like smoking, you will be able to gauge how effective your dose is fairly quickly. Smoking is also a fairly inexpensive method to dosing, but combustion can be harmful to the lungs and is not ideal for patients suffering lung damage, asthma, or emphysema. Similarly, vaporization offers almost instant relief, and it's much less harmful to the lungs. 

Other methods, like edibles, can take a long time to take effect, so you may not want to increase your dose until you have waited at least an hour. Once in effect, however, the relief they produce can last for hours. Many thing edibles can be measured at a more precise level than other methods, and they are a great alternative for patients who do not want to inhale their medication. The effects can be radically different from other methods of administration, and can be longer lasting and stronger. Patients should use caution when trying edibles for the first. time. 

Fortunately, if you're just starting out with medical marijuana and fear experimentation, our tool can help you along the process. As you begin to experiment with your regimen, you can keep track of it by journaling on a daily basis so that you can monitor what does and does not work for treating your symptoms. You can use our Medical Officer approved base guidelines for specific symptoms, and then titrate your dose until they adequately meet your needs. This post has been provided in part by the Medicinal Marijuana Association and approved by our Chief Medical Officer. 

Clinical Study Confirms Effectiveness of CBD as Treatment for Seizures

Photo Credit: Pixabay

Photo Credit: Pixabay

Medical Marijuana Inc. recently released the results of a clinical trial involving CBD-based Real Scientific Hemp Oil for relief from Lennox Gastaut Syndrome (LGS). LGS is described as severe childhood encephalopathy that produces frequent seizures and cognitive impairment, and it had previously been considered treatment-resistant to conventional therapies. Recently, however, researchers have found CBD to be a more successful treatment option. This new study from Medical Marijuana Inc. found RHSO-X 5000 reduced seizures for 84% of their patients, and over half of the patients reported their seizures reduced by 75%. Another 17% of patients reported becoming seizure free. Additionally, 89% of patients reported an improved quality of life without experiencing negative or severe side effects. 

This information has been provided by Merry Jane and approved by our Chief Medical Officer. 

Medical Marijuana Legalization Associated with Fewer Opioid-Related Hospitalizations

Data published in the journal Drug and Alcohol Dependence suggests statewide medical marijuana access reduces opioid-related hospitalizations. A researcher from the University of California at San Diego analyzed medical cannabis laws and opioid-related hospitalizations and found both immediate and long-term reductions in these hospitalizations following the implementation of such laws. The author reported, “This study demonstrated significant reductions on OPR- (opioid pain reliever) related hospitalizations associated with the implementation of medical marijuana policies. … We found reductions in OPR-related hospitalizations immediately after the year of policy implementation as well as delayed reductions in the third post-policy year.” The author also stated, “While the interpretation of the results should remain cautious, this study suggested that medical marijuana policies were not associated with marijuana-related hospitalizations. Instead, the policies were unintendedly associated with substantial reductions in OPR related hospitalizations.”

This information has been provided by The Daily Chronic and approved by our Chief Medical Officer. 

Study: CBD-Dominant Cannabis Extracts Reduce Seizure Frequency

Photo Credit: the Daily Chronic

Photo Credit: the Daily Chronic

Recent data published in the journal Epilepsy & Behavior suggests whole-plant cannabis extracts that contain high levels of CBD are associated with reduced seizure frequency in patients with refractory epilepsy. Researchers reviewed the clinical records of 272 patients who were taking whole-plant CBD extracts and found 86% of them observed clinical benefit, or a reduction in seizure frequency, while 10% experienced complete clinical response. The other patients either felt no relief or experienced an exacerbation of seizures during therapy. Patients also reported improved mood, better sleep quality, and increased appetite. Authors concluded, “The cannabinoids’ novel mechanisms of action are an attractive consideration for possible seizure control... In patients with refractory epilepsy that have a low likelihood of responding to a subsequent AED (anti-epileptic drug), a trial of artisanal cannabis formulas may be indicated.”

This information has been provided by the Daily Chronic and approved by our Chief Medical Officer. 

The Role of Medical Marijuana in Hospice Care

Photo Credit: Medical Marijuana Inc.

Photo Credit: Medical Marijuana Inc.

Hospice care consists of individually-tailored care programs for terminally ill patients who are in their final stages of life. The main focus of hospice care is to manage pain and other symptoms so that the patient can pass comfortably. Hospice patients may face pain, anxiety, spasms, nausea, and appetite or sleep problems, all of which cannabis can help manage. Both THC and CBD have been found to effectively lower pain levels that had previously proven unresponsive to traditional treatments. Studies have also found medical cannabis can improve muscle spasticity for extra relief. CBD lowers anxiety and stress levels, which can benefit emotional health of those under hospice care. Additionally, CBD reduces cognitive impairment and discomfort under stressful situations. THC can stimulate appetite with those who struggle to eat, and both THC and CBD can help regulate nausea and vomiting. Lastly, THC can help improve the quality and duration of sleep so that patients fall asleep quickly and better sleep through the night. 

This information has been provided by Medical Marijuana, Inc. and approved by our Chief Medical Officer.